Literature DB >> 22212473

Proteinuria in AMPD2-deficient mice.

Keiko Toyama1, Hiroko Morisaki, Jidong Cheng, Hiroshi Kawachi, Fujio Shimizu, Masahito Ikawa, Masaru Okabe, Takayuki Morisaki.   

Abstract

The AMPD2 gene, a member of the AMPD gene family encoding AMP deaminase, is widely expressed in nonmuscle tissues including kidney, although its functions have not been fully elucidated. In this study, we studied the function of the AMPD2 gene by establishing AMPD2-deficient model animal. We established AMPD2 knockout mice by using gene transfer and homologous recombination in murine ES cells and studied phenotypes and functions in the kidneys of these animals. AMPD activity was decreased from 22.9 mIU/mg protein to 2.5 mIU/mg protein in the kidneys of AMPD knockout mice. In addition to changes in nucleotide metabolism in the kidneys, proteinuria was found in 3-week-old AMPD2 knockout mice, followed by a further increment up to a peak level at 6 weeks old (up to 0.6 g/dL). The major protein component in the urine of AMPD2 knockout mice was found to be albumin, indicating that AMPD2 may have a key role in glomerular filtration. Indeed, an ultrastructure study of glomerulus specimens from these mice showed effacement of the podocyte foot processes, resembling minimal-change nephropathy in humans. Based on our results, we concluded that AMPD2 deficiency induces imbalanced nucleotide metabolism and proteinuria, probably due to podocyte dysfunction.
© 2012 The Authors. Journal compilation © 2012 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22212473     DOI: 10.1111/j.1365-2443.2011.01568.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  5 in total

1.  Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9.

Authors:  Fanny Kortüm; Rami Abou Jamra; Malik Alawi; Susan A Berry; Guntram Borck; Katherine L Helbig; Sha Tang; Dagmar Huhle; Georg Christoph Korenke; Malavika Hebbar; Anju Shukla; Katta M Girisha; Maja Steinlin; Sandra Waldmeier-Wilhelm; Martino Montomoli; Renzo Guerrini; Johannes R Lemke; Kerstin Kutsche
Journal:  Eur J Hum Genet       Date:  2018-02-20       Impact factor: 4.246

2.  AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder.

Authors:  Naiara Akizu; Vincent Cantagrel; Jana Schroth; Na Cai; Keith Vaux; Douglas McCloskey; Robert K Naviaux; Jeremy Van Vleet; Ali G Fenstermaker; Jennifer L Silhavy; Judith S Scheliga; Keiko Toyama; Hiroko Morisaki; Fatma M Sonmez; Figen Celep; Azza Oraby; Maha S Zaki; Raidah Al-Baradie; Eissa A Faqeih; Mohammed A M Saleh; Emily Spencer; Rasim Ozgur Rosti; Eric Scott; Elizabeth Nickerson; Stacey Gabriel; Takayuki Morisaki; Edward W Holmes; Joseph G Gleeson
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

3.  A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in mice.

Authors:  Joan Helmering; Todd Juan; Chi Ming Li; Mark Chhoa; Will Baron; Tibor Gyuris; William G Richards; James R Turk; Jeff Lawrence; Patrick A Cosgrove; Jim Busby; Ki Won Kim; Stephen A Kaufman; Connie Cummings; George Carlson; Murielle M Véniant; David J Lloyd
Journal:  Lipids Health Dis       Date:  2014-10-31       Impact factor: 3.876

4.  Effect of decaffeinated coffee on function and nucleotide metabolism in kidney.

Authors:  I M Rybakowska; R Milczarek; E M Slominska; R T Smolenski
Journal:  Mol Cell Biochem       Date:  2017-08-02       Impact factor: 3.396

5.  Role of AMPD2 in impaired glucose tolerance induced by high fructose diet.

Authors:  Athanasius Wrin Hudoyo; Tetsuaki Hirase; Andreas Tandelillin; Masahiko Honda; Manabu Shirai; Jidong Cheng; Hiroko Morisaki; Takayuki Morisaki
Journal:  Mol Genet Metab Rep       Date:  2017-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.